Last reviewed · How we verify
NCT05322109
Cardiac Magnetic Resonance Tomography for Heart Failure With Preserved Ejection Fraction
trial testing CMR in Heart Failure, Diastolic in 190 participants. Completed in 12 December 2021.
12 December 2021
Quick facts
| Lead sponsor | German Heart Institute |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 190 |
| Start date | 23 April 2021 |
| Primary completion | 12 December 2021 |
| Estimated completion | 12 December 2021 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- CMR
Conditions studied
- Heart Failure, Diastolic — all drugs for Heart Failure, Diastolic →
Sponsor
German Heart Institute
Who can join
18 and older, any sex, with Heart Failure, Diastolic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The diagnosis of heart failure with preserved ejection fraction has so far been made primarily according to criteria determined by echocardiography, or invasively by measuring the left ventricular filling pressures. Increasingly, CMR is also evaluated with regard to the diagnosis of cardiac insufficiency with preserved pump function.However, it is still unclear which parameters can be used meaningfully for diagnostics.To answer this question, the investigators want to retrospectively evaluate data collected from patients with a clinical indication for CMR and coronary angiography.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05322109
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CMR
Trials testing the same drug.
- NCT07131111 — Impact of Aortic Geometry on Vascular Remodeling After Stent Implantation in Coarctation of the Aorta · not yet recruiting
- NCT06780241 — Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease · recruiting
- NCT06323811 — Comparison of Free-breathing 3D Quantitative Perfusion in Patients With MINOCA and MINOCA-mimics · NA · unknown
- NCT06266858 — Multimodality Imaging Assessment of the Severity of Mitral Regurgitation · NA · unknown
- NCT05239260 — Impact of Fluid Status on Liver Elastography and T1-mapping Results in Patients Undergoing CMR. · unknown
Other recruiting trials for Heart Failure, Diastolic
Currently open trials in the same condition.
- NCT07199088 — Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Ac · NA · recruiting
- NCT05887271 — A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejec · Phase 2, PHASE3 · recruiting
- NCT05989945 — HIDRAdenitis Suppurativa and HEART Disease · active not recruiting
- NCT05752760 — Pilot Study Lp299v Supplementation in Chronic Heart Failure · NA · recruiting
- NCT06084468 — Cardiac Structure and Function in Patients with Cystic Fibrosis · active not recruiting
Other German Heart Institute trials
Trials by the same sponsor.
- NCT07320560 — Personalized Atrial Fibrillation Ablation Guided by Non-Invasive Global Mapping · NA · recruiting
- NCT07185100 — Determination of the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using · recruiting
- NCT06246188 — Use of Stress-CMR Using Regadenoson and GE-267 in Adult Patients with Known or Suspected Coronary Artery Disease · not yet recruiting
- NCT06689098 — Magnetocardiography as a Diagnostic Screening Tool for Myocarditis and Other Types of Cardiomyopathy · completed
- NCT05826444 — Microvascular Cardiac Allograft Vasculopathy Trial · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05322109 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by German Heart Institute
- Last refreshed: 11 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05322109.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing